Lexaria Bioscience Corp. (LEXX) vs Skye Bioscience, Inc. (SKYE)

Lexaria Bioscience Corp. and Skye Bioscience, Inc. are both Biotechnology companies. Lexaria Bioscience Corp. and Skye Bioscience, Inc. are of similar size ($7.5M and $7.1M). Across the 11 metrics below, Lexaria Bioscience Corp. leads on 10 and Skye Bioscience, Inc. on 1.

Valuation

Metric LEXX SKYE Biotechnology median
P/E n/m n/m 7.88
P/S 10.01 27.76 11.47
P/B 1.25 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3.66 14.91 10.73
Earnings yield (155.41%) (608.38%) (28.84%)
Free cash flow yield (138.70%) (461.87%) (23.03%)

Profitability

Metric LEXX SKYE Biotechnology median
Gross margin 100.00% 68.04% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (162.60%) (233.87%) (57.72%)
Return on assets (134.20%) (159.80%) (49.22%)
Return on invested capital (662.56%) 0.00% 0.00%

Growth

Metric LEXX SKYE Biotechnology median
Revenue growth (TTM) 9.08% — 5.64%
EPS growth (last fiscal year) (40.43%) (93.15%) —
Revenue growth, 5-year CAGR 17.53% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEXX SKYE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.60 0.95 4.73
Net debt to EBITDA 0.17 0.45 0.96

Dividend

Metric LEXX SKYE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric LEXX SKYE Biotechnology median
Market cap 7.10m 7.53m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack